Vikas Lifecare Limited (VIKASLIFE) AI Stock Analysis

• Market Cap: ₹4.11B
• Dividend Yield: N/A
• Average Volume (3M): 1.31M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.41
• Revenue Growth: 9.42%
• EPS Growth: -12220.00%
• Country: IN
• Employees: 36
• Sector: Healthcare
• Sector Strength: 45
• Industry: Chemicals - Specialty
• EPS (TTM): -0.02
• Shares Outstanding: 1,857,668,600
• 10 Day Avg. Volume: 1,238,380
• 30 Day Avg. Volume: 1,307,748
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹2.50
• Price Target Upside: 13.12% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 47 Neutral
• Price Target: ₹2.50 ▲(13.12% Upside)

Vikas Lifecare Limited's stock score is low, driven by challenging financial performance, weak technical indicators, and unattractive valuation metrics. The company's operational and cash flow inefficiencies pose significant risks, overshadowing its strong equity structure.

Vikas Lifecare Limited Business Overview & Revenue Model

Company Description

Vikas Lifecare Limited engages in the trading of various chemicals compounds, polymers, PVC resins, plastic granules, and products related to plastic industry in India. It operates through Real Estate, Trading- Polymers, Trading-Cashew Nuts, and Manufacturing divisions. The company is also involved in the real estate business; and the manufacture of recycled material for automotive, packaging, sheathing, and textile industries. In addition, it manufactures and sells polymer compounds, which include PE, PVC, V blend SOE, and polypropylene compounds, as well as thermo plastic rubber; deals in FMCG, cashew nuts, aluminum foils, and processed food products. Vikas Lifecare Limited also exports its products. The company was formerly known as Vikas Multicorp Limited and changed its name to Vikas Lifecare Limited in April 2021. Vikas Lifecare Limited was incorporated in 1995 and is based in New Delhi, India.

How the Company Makes Money

Vikas Lifecare Limited generates revenue through multiple streams, primarily focusing on the trading and recycling of polymers and chemicals. The company's revenue model includes sourcing and supplying virgin and recycled polymers to various industries, including packaging, automotive, and construction. Additionally, it earns income from the sale of specialty additives that enhance the properties of polymers. Strategic partnerships with suppliers and customers help Vikas Lifecare optimize its supply chain and distribution network, enhancing its market presence and profitability. The company's focus on sustainability and recycling initiatives also positions it to capitalize on the growing demand for environmentally friendly materials.

Vikas Lifecare Limited Financial Statement Overview

Summary

Vikas Lifecare Limited is facing financial challenges with declining profitability, increased debt, and negative cash flows. Despite maintaining a strong equity base, significant improvement in operational performance is required to enhance financial health.

Income Statement

Vikas Lifecare Limited has shown volatile revenue growth with a notable decline in profitability. The gross profit margin is low, indicating cost pressures, and the net profit margin has deteriorated into negative territory, reflecting operational challenges. The EBIT and EBITDA margins have also weakened, contributing to financial instability.

Balance Sheet

The balance sheet demonstrates a moderate debt-to-equity ratio, suggesting a balanced approach to leveraging, though the debt has increased significantly over the year. The return on equity is negative due to net losses, but the equity ratio remains strong, indicating solid capital structure despite profitability challenges.

Cash Flow

Cash flow analysis reveals negative free cash flow growth and poor operating cash flow, indicating liquidity challenges. The operating cash flow to net income ratio is negative, reflecting operational inefficiencies. The company needs to improve cash generation to support its operations.

Breakdown	TTM	Dec 2025	Dec 2023	Dec 2022	Dec 2022	Dec 2021
Income Statement
Total Revenue	4.76B	4.80B	4.46B	3.01B	4.76B	749.95M
Gross Profit	124.01M	38.79M	262.04M	101.59M	243.20M	112.35M
EBITDA	25.49M	43.56M	240.93M	427.24M	-160.98M	43.39M
Net Income	-90.44M	-106.14M	140.29M	286.99M	-152.99M	-35.02M
Balance Sheet
Total Assets	0.00	7.29B	5.55B	3.21B	4.55B	1.49B
Cash, Cash Equivalents and Short-Term Investments	20.80M	431.74M	159.36M	77.05M	114.00M	1.88M
Total Debt	0.00	767.00M	344.90M	230.77M	304.07M	417.57M
Total Liabilities	-5.45B	1.96B	762.67M	1.21B	1.21B	822.82M
Stockholders Equity	5.45B	5.32B	4.77B	1.99B	3.31B	666.70M
Cash Flow
Free Cash Flow	0.00	-2.36B	-577.20M	-281.03M	-1.28B	-91.52M
Operating Cash Flow	0.00	-2.24B	-417.48M	-148.84M	-1.10B	-76.82M
Investing Cash Flow	0.00	1.03B	-906.01M	-385.14M	-366.38M	119.21M
Financing Cash Flow	0.00	1.12B	1.37B	590.87M	1.51B	-42.69M

Vikas Lifecare Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.21
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VIKASLIFE, the sentiment is Negative. The current price of 2.21 is below the 20-day moving average (MA) of 2.25, below the 50-day MA of 2.31, and below the 200-day MA of 2.95, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 40.53 is Neutral, neither overbought nor oversold. The STOCH value of 6.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VIKASLIFE.

Vikas Lifecare Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ALBERTDAVD	65 Neutral	₹4.45B	70.70	4.38%	0.64%	-9.14%	-91.11%
LYKALABS	58 Neutral	₹3.39B	45.17	7.74%	―	19.40%	1286.88%
MEDICAMEQ	54 Neutral	₹4.13B	41.20	3.34%	0.33%	-9.90%	33.18%
ZIMLAB	54 Neutral	₹3.57B	38.06	4.82%	―	-3.36%	-47.58%
VIKASLIFE	47 Neutral	₹4.11B	―	―	―	9.42%	-12220.00%
NECLIFE	43 Neutral	₹3.26B	-1.81	-11.89%	―	-3.41%	-3028.44%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%